A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects

Clinical trial NCT04913090 · UNKNOWN

Trial details

NCT number: NCT04913090
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH)

Start date: 2021-05-31
Primary completion: 2022-03-04
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.